跳至主要内容
临床试验/NCT00470288
NCT00470288Unknown不适用

Randomized Controlled Trial of Bladder Flap vs.None

Mountain Area Health Organization Center1 个研究点 分布在 1 个国家目标入组 123 人开始时间: 2005年10月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
123
试验地点
1
主要终点
operative time: start of surgery to delivery of infant

研究概览

简要总结

Objective: To compare outcomes in cesarean section patients undergoing bladder flap versus none. Hypotheses: Operative time will be reduced with the elimination of a bladder flap during cesarean delivery and intra-operative and post-operative morbidity will not be significantly different.

Patients >= 35 wks gestation undergoing cesarean delivery will be randomized to bladder flap vs. none. Primary outcome is operative time (start to delivery); secondary outcomes include: injuries, EBL, intra-operative and post-operative complications,pain medication, hospital stay duration.

详细描述

  1. Title A Randomized Controlled Trial of Bladder Flap vs. None in Cesarean Section
  2. Background (This section should be used to provide a rationale for the conduct of the study. Refer to existent or preliminary studies as necessary) The standard of care in performing cesarean delivery is to perform a bladder flap in the procedures.1 The creation of a bladder flap essentially allows a surgeon to create a space between the uterus and the bladder so that he/she has better access to the lower portion of the uterus where a low transverse incision can be made. This procedure involves making a superficial incision into the peritoneum, or the cell lining of the abdominal cavity, and the moving the bladder down and away from the lower portion of the uterus. A retractor or a bladder blade is then inserted into this space to hold the bladder away from the uterus (see Appendix A).2 Use of the bladder flap in cesarean delivery dates back to 1878 in the pre-antibiotic era,3 and theoretically, the bladder flap allows better access to the low portion of the uterus while decreasing risk of bladder injury and infection. However, several recent but small studies suggest the inclusion of the bladder flap confers no advantage and may actually contribute to greater morbidity postoperatively. 4-5 Additionally, the incidence of bladder injuries is 0.3%, and most injuries resulted during the formation of the bladder flap.6 The evidence from these studies are limited by the inclusion of other modifications in surgical procedures and a lack of replication of results, respectively. Thus there is insufficient evidence to either support or reject the inclusion of bladder flaps in cesarean deliveries (Evidence grade C).7-8
  3. Specific Objectives (Enumerate the objectives and nature of the measured end-points. Justify the use of surrogate clinical end-points as necessary)

1. To compare outcomes in cesarean section patients undergoing bladder flap versus none.

4. Study design (Explicate the nature of the study - observational vs experimental. Differentiate between cohort, case-control, and cross-sectional and randomized clinical trials. For the latter, provide sufficient supporting justification for the experimental arm. If it is a placebo-controlled trial, please state whether clinical equipoise exists between the placebo and experimental arm.) Randomized controlled trial.

Endpoints:

Total operating time (continuous) and Time of delivery to end of surgery (continuous) Estimated blood loss (continuous) Post operative fever (categorical) Bladder injury (categorical) Pre- and post-operative pain medication (continuous) and Analog pain scale (continuous)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single

入排标准

性别
Female
接受健康志愿者
是

入选标准

  • •Cesarean delivery at >=35 weeks gestation;
  • •Able to provide informed consent

排除标准

  • •Vaginal delivery;
  • •Delivery < 35 weeks gestation;
  • •STAT surgery;
  • •Unable to provide consent;
  • •Medical complication/condition incompatable with random asiignment

结局指标

主要结局

operative time: start of surgery to delivery of infant

时间窗: immediate: during cesarean surgery

次要结局

  • estimated blood loss(immediate)
  • bladder injuries(immediate)
  • other intra-operative complications(immediate)
  • intra-operative transfusions(immediate)
  • post-operative complications(post-op hospitalization)
  • medication use: antibiotics and narcotics(post-op hospitalization)
  • duration of post-op hospitalization(post-op hospitalization)
  • readmisison post discharge(6 weeks post-op)

研究者

发起方
Mountain Area Health Organization Center
申办方类型
Other

研究点 (1)

Loading locations...

相似试验